Loading...
Docoh

Odyssey Health (ODYY)

Employees
Data from SEC filings
Employee count
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On September 14, 2021, Odyssey Group International, Inc. (“Odyssey) held its 2021 Annual Meeting of Stockholders. At the Annual Meeting, the stockholders: (1) elected each of Joseph Michael Redmond, Jerome H. Casey, Jeffrey Conroy, John P. Gandolfo and Ricky W. Richardson to Odyssey’s Board of Directors for a term of one year to serve until the 2022 annual meeting of stockholders and until a successor is elected; (2) approved the non-binding, advisory vote to approve the compensation of the named executive officers; (3) recommended the non-binding, advisory vote to set the frequency of the vote on executive compensation; (4) approved the proposal regarding the Amended and Restated 2021 Omnibus Stock Incentive Plan; (5) approved an amendment to our Amended and Restated Articles of Incorporation to effect a reverse stock split of our outstanding Common Stock; (6) approved the amendment to Article One of our Amended and Restated Articles of Incorporation for the purpose of changing our name from “Odyssey Group International, Inc.” to “Odyssey Health, Inc.”; and (7) ratified the appointment of Turner Stone & Company as Odyssey’s independent registered public accounting firm for the fiscal year ending July 31, 2021.

The number of votes cast in favor or against or withheld by the stockholders and, where applicable, the number of abstentions and the number of broker nonvotes on each of the foregoing matters are set forth below.

Proposal #1: Election of Directors

Shares Voted to
Shares Withhold
Nominee Voted For Authority
Joseph M. Redmond41,041,751145,543
Jerome H. Casey41,040,751146,543
Jeffrey Conroy41,040,751146,543
John P. Gandolfo41,041,751145,543
Ricky W. Richardson41,041,751145,543

Proposal #2: To Approve on an Advisory Basis Executive Compensation

Shares Shares Voted Shares Broker
Voted For Against Abstaining Nonvotes
40,237,368479,327470,5993,270,132

Proposal #3: Recommend Frequency of Advisory Vote on Executive Compensation

One YearTwo YearsThree YearsAbstain
40,484,261497,55093,495111,988


Proposal #4: Approve the Amended & Restated 2021 Omnibus Stock Incentive Plan

Shares Shares Voted Shares
Voted For Against Abstaining
40,395,017242,926549,351

Proposal #5: To Effect a Reverse Stock Split of Outstanding Common Stock

Shares Shares Voted Shares
Voted For Against Abstaining
42,937,1501,257,862262,414


2


Proposal #6: Approve Name Change to "Odyssey Health, Inc."

Shares Shares Voted Shares
Voted For Against Abstaining
43,692,536351,572413,318

Proposal #7: Ratify Turner Stone & Company LLP as Auditors

Shares Shares Voted Shares
Voted For Against Abstaining
44,261,71167,113128,602


3